Does anyone have a guess on when we might see India revenues? EOM | NAVB Message Board Posts


Navidea Biopharmaceuticals, Inc.

  NAVB website

NAVB   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  38262 of 38624  at  10/1/2022 8:23:02 AM  by

ddin


 In response to msg 38252 by  AG_Trader10
view thread

Re: Does anyone have a guess on when we might see India revenues? EOM

I posted this before, and I haven't seen any update since. First milestone was to have happened a quarter ago.

Q1CC:
We also recently press release the regulatory approval of lymphoseek as lymphoaim in India. As mentioned in that release, our partner in India, Sayre Therapeutics will lead the commercialization efforts there. We're delighted that lymphoaim has received regulatory approval in India and will be available to patients in need. There is a small milestone payment due for completion of the regulatory application inquiry process, as well as another due upon receipt of the import license. We'd expect that first payment by the end of this quarter.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
38263 Re: Does anyone have a guess on when we might see India revenues? EOM NAVB2023 1 10/1/2022 9:47:06 AM




Financial Market Data provided by
.
Loading...